Genentech: Encouraging innovation

Genentech is the only drug company to offer a postdoc program; just one reason it's No. 7 on the Best Companies to Work For list.

EMAIL  |   PRINT  |   SHARE  |   RSS
 
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
By Christopher Tkaczyk, reporter
Last Updated: September 29, 2009: 1:48 PM ET

genentech_chiefs.03.jpg
Research chiefs Richard Scheller, left, and Marc Tessier-Lavigne, framed by Genentech's founders
lori_friedman.03.jpg
Why I work here
Lori Friedman, cancer researcher at Genentech
"People are very motivated to think of the endgame. How do we make the right drug? How's this going to help the patient? And I think it's that sense of mission that really brings people together in the community of researchers here."

(Fortune Magazine) -- Genentech, the South San Francisco biotech company, has a long history of developing revolutionary drugs like cancer fighter Avastin. But such breakthroughs are no accident -- they're a result of a culture that puts a premium on curiosity and creativity.

Perhaps the best example: Genentech is the only pharmaceutical company to offer a postdoctoral program, where up to 120 Ph.D. holders are awarded fellowships for four years. Rather than work on drug-related projects, these brainiacs are encouraged to follow their interests and focus on fundamental research that could later apply to potential products.

Though the company was recently acquired by Swiss drugmaker Roche, its approach to fostering innovation hasn't changed. Richard Scheller, Genentech's head of research, explains how the company keeps innovation flowing.

Refresh talent often.
"The postdoc program keeps a constant flux of young people with different backgrounds and technologies moving through Genentech. This keeps the real innovative, entrepreneurial, creative spirit around Genentech research. It rubs off on everyone in the group."

Encourage risk taking.
"People are encouraged to work on projects that are high risk. We expect that the projects might not work -- in fact, most of them won't. But those that do work often end up being true breakthroughs."

Share your results.
"We always have a number of key papers in the top scientific journals every year, comparable to major institutions around the world, such as MIT, Stanford, and Harvard. So the outside world has a respect for Genentech that is quite different from that for other pharmaceutical companies."

Perks that work

Retention pay
As a result of the Roche merger, employees hired as of Aug. 18, 2008 who remained with the company received retention bonuses. Some 11,000 employees shared $182 million. A second round of retention bonuses is planned for March 2010, a year following the deal's completion.

Fun competitions
A photo-of-the-week competition -- combined with creative costumes -- inspires a dose of frivolity. One group dressed up as the rock band Kiss for a corporate meeting.

Concierge
A service is available to help employees secure dinner reservations or theater tickets, as well as run other errands. Spouses and partners can also use the benefit.

Clean clothes (and teeth)
An onsite laundry and dry-cleaning pickup and delivery service handles 3,000 articles of clothing a month; an onsite health van offers a state-of-the-art dentist's office. To top of page

CompanyPrice% Change
YRC Worldwide Inc 1.04 -8.78%
Chiquita Brands International Inc 17.92 7.18%
Gannett Co Inc 15.40 6.87%
MGM Mirage Inc 9.74 6.68%
Dec 23 3:33pm ET †
IndexLast% Change
Dow Jones10,458.05-0.07%
Nasdaq2,266.740.62%
S&P 5001,119.590.14%
10yr96 28/32Yield: 3.75%
Dec 23 3:36pm ET †
CompanyPrice% Change
Micron Technology Inc 9.94 5.63%
eBay Inc 24.07 5.02%
Yahoo! Inc 16.65 4.16%
Amazon.com Inc 138.84 3.80%
Dec 23 3:33pm ET †
More Galleries
Biggest losers: Where Americans aren't moving Through most of the decade Florida was one of the fastest growing states. But the sunny clime -- and 6 others -- lost more residents than they gained in the year ended July 1. More
8 hot cars: Class of 2000 In just 10 years, the market's changed a lot when it comes to cars. Where are these models now? The Prius became a hit; the Aztek got killed. More
Obama's Main Street favorites President Obama meets often with small business owners, peppering his speeches with their stories. We checked in with 6 entrepreneurs touted by the President to find out how they handle health care. More
Sponsors
The 'ugly' side of alternative energy
In places like the Mojave Desert, some fight to preserve the landscape and prevent the installation of solar panels. Play
PIMCO CEO: Recovery may not last
Mohamed El-Erian says as the government unwinds its stimulus spending, the economy may dip back into a recession. Play
Security biz risk taker
The owner of Picore Worldwide has learned to delegate tasks to free up her time to grow the company. Play

© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.